https://www.selleckchem.com/products/odm208.html
65% vs. 1.44%, hazard ratio (HR) 1.87, 95% confidence interval (CI) 1.43-2.45), and acute myocardial infarction (1.51% vs. 0.30%, HR 5.34, 95% CI 3.40-8.39) compared to the nonstatin group (n = 1709). The risk of all-cause mortality, cardiovascular (CV) death. and stroke did not significantly differ between the two groups. Similar to older patients, this study demonstrated that statin therapy cannot offer any protective effects in reducing CV outcomes among young adult ESRD patients undergoing dialysis.Immune checkpoint inhibitor (ICI) t